只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-20 2026-07-20 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Soares Karen Officer · Chief Legal Officer | 卖出（S） | 51,700 | US$4.51 | US$233,167.00 | 1,505,522 | SEC |
| 2026-07-17 2026-07-17 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. Officer · CEO, Medicare Advantage | 卖出（S） | 4,839 | US$4.53 | US$21,920.67 | 2,814,640 | SEC |
| 2026-07-15 2026-07-16 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | THORNTON JOSEPH CLAY Officer · Interim CFO | 卖出（S） | 4,630 | US$4.67 | US$21,622.10 | 1,212,954 | SEC |
| 2026-07-15 2026-07-16 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Soares Karen Officer · Chief Legal Officer | 卖出（S） | 10,519 | US$4.67 | US$49,123.73 | 1,557,222 | SEC |
| 2026-07-15 2026-07-16 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. Officer · CEO, Medicare Advantage | 卖出（S） | 13,119 | US$4.67 | US$61,265.73 | 2,819,479 | SEC |
| 2026-07-15 2026-07-16 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Wai Conrad Officer · CEO, Counterpart Health | 卖出（S） | 24,215 | US$4.67 | US$113,084.05 | 1,145,699 | SEC |
| 2026-07-15 2026-07-16 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Toy Andrew Director,Officer · Chief Executive Officer | 卖出（S） | 62,711 | US$4.67 | US$292,860.37 | 9,547,114 | SEC |
| 2026-07-08 2026-07-09 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. Officer · CEO, Medicare Advantage | 卖出（S） | 2,384 | US$4.68 | US$11,157.12 | 2,832,598 | SEC |
| 2026-07-06 2026-07-06 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. Officer · CEO, Medicare Advantage | 卖出（S） | 6,229 | US$5.26 | US$32,764.54 | 2,834,982 | SEC |
| 2026-07-01 2026-07-01 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Toy Andrew Director,Officer · Chief Executive Officer | 卖出（S） | 313,476 | US$5.32 | US$166.77万 | 9,609,825 | SEC |
| 2026-06-17 2026-06-18 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. Officer · CEO, Medicare Advantage | 卖出（S） | 2,360 | US$4.78 | US$11,280.80 | 2,841,211 | SEC |
| 2026-06-16 2026-06-17 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | OLDAKOWSKI JOSEPH FRANK Officer · VP OF FINANCE AND CONTROLLER | 卖出（S） | 12,102 | US$4.86 | US$58,815.72 | 299,067 | SEC |
| 2026-06-15 2026-06-16 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Soares Karen Officer · Chief Legal Officer | 卖出（S） | 4,681 | US$4.61 | US$21,579.41 | 1,567,741 | SEC |
| 2026-06-15 2026-06-16 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. Officer · CEO, Medicare Advantage | 卖出（S） | 6,350 | US$4.61 | US$29,273.50 | 2,843,571 | SEC |
| 2026-06-11 2026-06-11 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Reynoso Jamie L. Officer · CEO, Medicare Advantage | 卖出（S） | 7,289 | US$4.91 | US$35,788.99 | 2,849,921 | SEC |
| 2026-05-28 2026-05-28 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Wai Conrad Officer · CEO, Counterpart Health | 卖出（S） | 220,426 | US$3.99 | US$879,499.74 | 1,390,056 | SEC |
| 2026-05-18 2026-05-19 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Edwards Carladenise Armbrister Director | 卖出（S） | 67,160 | US$3.42 | US$229,687.20 | 285,432 | SEC |
| 2026-05-13 2026-05-13 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Priest Brady Patrick Officer · CEO of Clover Care Services | 卖出（S） | 98,039 | US$3.52 | US$345,097.28 | 2,040,222 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| CLOV | 454,528.2537 | 2,384 | 1,203,631.1641 | 37.76% | B, Q, N |